Want to join the conversation?
Medical technology company $LIVN said that it launched the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve. This device helps reduce the complexity of aortic valve replacement (AVR) by enhancing the speed and efficiency of the surgery, while providing optimized hemodynamic performance.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.